German, Healthcare

German Healthcare Law Slashes Benefits, Raises Patient Costs by Billions

Published on 07/28/2026 at 04:24 | Redaktion boerse-global.de

New German law shifts €18.8B burden to patients: drug co-pays rise, dental subsidies cut, and hospital deficits loom, sparking political backlash.

Germany Health Insurance Cost Hikes: GKV Patients Face Higher Co-Pays
German Healthcare Law Slashes Benefits, Raises Patient Costs by Billions Illustration mit AI erstellt ĂĽbermittelt durch boerse-global.de

Patients covered by Germany’s statutory health insurance (GKV) are facing a steep financial hit under a new cost-cutting law that shifts billions in expenses onto their shoulders. The GKV Contribution Rate Stabilization Act, passed in July, is designed to plug an €18.8 billion funding gap in the public healthcare system — but critics say it does so by squeezing those who can least afford it.

Starting immediately, co-payments for prescription drugs jump from a range of €5 to €10 to between €7.50 and €15. Dental prosthetics subsidies drop from 60% to 50% of costs, and homeopathic treatments are eliminated entirely from coverage. The changes don’t stop there. By 2027, the monthly income threshold for compulsory insurance will rise by €300, pulling more earnings into the contribution base. In 2028, a 2.5% surcharge on family insurance kicks in. Perhaps most quietly, since July, insurers are no longer required to notify members in writing about increases to their supplementary contribution rates. That means net pay can shrink without a formal warning — though the legal right to switch plans remains intact.

Hospitals Sound the Alarm on Rising Deficits

Bavaria’s district administrators are warning of a looming crisis. They project additional hospital deficits ranging from €950 million to €1.4 billion. The Wolfratshausen district hospital already posted a €3.1 million shortfall in 2024, while the Ebersberg clinic recorded a €14 million loss. In the Starnberg district, annual extra burdens of €5 million to €6 million are expected from 2027 onward.

The St. Francis Foundation in Münster and hospital operators in East Westphalia-Lippe anticipate revenue reductions of up to 8% in 2027. Inflation adjustments are being scrapped, and cost caps remain in place. The federal government has allocated €450 million for hospitals and €100 million for university clinics — but industry representatives call that woefully inadequate. Because German law requires counties to cover hospital deficits, the costs ultimately trickle down to municipalities through higher district levies.

Psychotherapy and Primary Care Under Strain

Mental health providers are raising red flags over the return of budget caps, which they say will cripple access. For a half-time practice slot, the number of patients treated weekly could drop from 22 to 18. Experts predict a wave of clinic closures starting in 2027. Wait times for psychotherapy already average over 100 days.

General practitioners are also bracing for shortages, compounded by an impending wave of retirements. One health economist described the package not as a sustainable reform but as a blunt rationing of care. His prescription: a fundamental overhaul of the GKV system and an emergency reform plan.

Political Battle Lines Harden

Health Minister Warken defends the law as essential to closing the €18.8 billion financial hole. But Hamburg’s First Mayor Tschentscher has called it a failure, arguing that non-insurance-related benefits continue to be funded from contributions rather than tax revenue.

Even before the law took effect, patients were already feeling the pinch. In 2025, average out-of-pocket costs for mobility aids like walkers or hearing aids reached €159 per case. Companies are also struggling to cover employees through occupational health insurance, as rigid tax-free allowance limits block subsidies.

The GKV-BStabG is scheduled for renegotiation in September, with the impact on psychotherapeutic services expected to be a key focus.

Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.

en | boerse | 69889333 |